Clinical Pharmacist-led Discharge Education Service in Acute Coronary Syndrome
Evaluation of a Clinical Pharmacist-led Discharge Education Service in Patients With Acute Coronary Syndrome: A Randomized Controlled Study
1 other identifier
interventional
177
1 country
1
Brief Summary
To evaluate the impact of clinical pharmacist-led discharge education service in patients with acute coronary syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2021
CompletedFirst Submitted
Initial submission to the registry
November 25, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedMarch 16, 2023
March 1, 2023
5 months
November 25, 2021
March 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
30 days hospital re-admission for cardiac reasons
Proportion of patients readmitted to hospital for cardiac cause at 1 month
30 days
Secondary Outcomes (9)
Hospital re-admission for cardiac reasons
3 months, 6 months, and 12 months
Hospital re-admission for any reasons
1 month, 3 months, 6 months, and 12 months
Emergency service visits
1 month, 3 months, 6 months, and 12 months
Major Adverse Cardiovascular Event
1 month, 3 months, 6 months, and 12 months
Death for cardiac reason
1 month, 3 months, 6 months, and 12 months
- +4 more secondary outcomes
Study Arms (2)
Clinical Pharmacist-led discharge education program
EXPERIMENTALClinical pharmacist-led services
Control group
NO INTERVENTIONUsual care
Interventions
medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally \[by using Teach back method especially for patients with low health literacy\]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model).
Eligibility Criteria
You may qualify if:
- Patients admitted to the cardiology department due to acute coronary syndrome
- Older than 18 years old
You may not qualify if:
- Patients who transferred to another ward
- Patients with active malignancy
- Patients with alzheimer and/or dementia diagnosis
- Patient with \>%80 visual loss or deaf muteness reported at medical record
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Betul Okuyan
Marmara University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.
Study Record Dates
First Submitted
November 25, 2021
First Posted
December 10, 2021
Study Start
January 15, 2021
Primary Completion
June 15, 2021
Study Completion
June 15, 2022
Last Updated
March 16, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share